BTSGU BrightSpring Health Services, Inc. - Tangible Equity Unit
$196.51
Price · Aug 18, 2026
Fundamentals as of Jul 31, 2026
52W Range
$80–$256
66% of range
Analyst Rating
BUY
25 analysts
Price Target
—
P/E (TTM)
—
ROE
—
Net Profit Margin
—
BTSGU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$196.51
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$80 – $256
BTSGU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BTSGU
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BTSGU
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BTSGU
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BTSGU
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BTSGU
Peer Median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Dividend Yield
—
Payout Ratio
—
5Y Div CAGR
—
| Ex-date | Amount |
|---|---|
| July 15, 2026 | $0.8440 |
| April 15, 2026 | $0.8440 |
| Jan. 15, 2026 | $0.8440 |
| Oct. 15, 2025 | $0.8440 |
| July 15, 2025 | $0.8440 |
| April 15, 2025 | $0.8440 |
| Jan. 15, 2025 | $0.8440 |
| Oct. 15, 2024 | $0.8440 |
| July 15, 2024 | $0.8440 |
BTSGU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
25 analysts
- Strong Buy 9 36.0%
- Buy 15 60.0%
- Hold 1 4.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.06%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $0.45 | $0.40 | 0.05% |
| March 31, 2026 | $0.39 | $0.32 | 0.07% |
| Dec. 31, 2025 | $0.33 | $0.36 | -0.03% |
| Sept. 30, 2025 | $0.39 | $0.28 | 0.11% |
| June 30, 2025 | $0.22 | $0.17 | 0.05% |
| March 31, 2025 | $0.19 | $0.10 | 0.09% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BTSGU | — | — | — | — | — | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet 25
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $88M | |
| Receivables | $990M | |
| Inventory | $815M | |
| Prepaid Expense | $119M | |
| Current Assets | $2.89B | |
| PP&E (Net) | $205M | |
| Accum. Depreciation | $405M | |
| Goodwill | $2.55B | |
| Intangibles | $558M | |
| Other Non-current Assets | $40M | |
| Total Assets | $6.41B | |
| Accounts Payable | $1.22B | |
| Accrued Liabilities | $333M | |
| Current Liabilities | $1.85B | |
| Capital Leases | $135M | |
| Deferred Tax | $6M | |
| Other Non-current Liabilities | $2M | |
| Total Liabilities | $4.53B | |
| Long-term Debt | $2.51B | |
| Common Stock | $2M | |
| Retained Earnings | $-75M | |
| AOCI | $-7M | |
| Stockholders' Equity | $1.88B | |
| Liabilities + Equity | $6.41B | |
| Shares Outstanding | 192,124,125 |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $3.87B | $3.61B | $2.88B | |
| Gross Profit | $493M | $482M | $338M | |
| SG&A Expense | $362M | $361M | $288M | |
| Operating Income | $130M | $121M | $51M | |
| Interest Expense | $37M | $39M | $42M | |
| Pretax Income | $94M | $83M | $9M | |
| Income Tax | $7M | $9M | $-240.0K | |
| Net Income | $84M | $149M | $30M | |
| EPS (Basic) | $0.41 | $0.73 | $0.15 | |
| EPS (Diluted) | $0.38 | $0.67 | $0.14 | |
| Shares (Basic) | 206,042,000 | 204,712,000 | 201,005,000 | |
| Shares (Diluted) | 220,276,000 | 221,321,000 | 214,927,000 | |
| EBITDA | $130M | $121M | · |
Balance Sheet 26
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $550M | $889M | · | |
| Receivables | $1.14B | $1.11B | · | |
| Inventory | $575M | $560M | · | |
| Prepaid Expense | $205M | $127M | · | |
| Current Assets | $2.47B | $2.69B | · | |
| PP&E (Net) | $214M | $202M | · | |
| Accum. Depreciation | $439M | $421M | · | |
| Goodwill | $2.54B | $2.53B | · | |
| Intangibles | $514M | $537M | · | |
| Other Non-current Assets | $85M | $78M | · | |
| Total Assets | $5.99B | $6.21B | · | |
| Accounts Payable | $1.09B | $1.09B | · | |
| Accrued Liabilities | $372M | $352M | · | |
| Current Liabilities | $1.56B | $1.55B | · | |
| Capital Leases | $132M | $137M | · | |
| Deferred Tax | $636.0K | $1M | · | |
| Other Non-current Liabilities | $2M | $849.0K | · | |
| Total Liabilities | $3.93B | $4.22B | · | |
| Long-term Debt | $2.19B | $2.50B | · | |
| Total Debt | $2.19B | $2.50B | · | |
| Common Stock | $2M | $2M | · | |
| Retained Earnings | $38M | $14M | · | |
| AOCI | $4M | $-1M | · | |
| Stockholders' Equity | $2.05B | $1.98B | · | |
| Liabilities + Equity | $5.99B | $6.21B | · | |
| Shares Outstanding | 197,509,491 | 193,209,722 | · |
Cash Flow 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| D&A | $41M | $39M | $42M | |
| Stock-based Comp | $19M | $4M | $16M | |
| Amort. of Intangibles | $22M | $21M | $23M | |
| Operating Cash Flow | $44M | $123M | $102M | |
| CapEx | $29M | $22M | $18M | |
| Investing Cash Flow | $-28M | $747M | $-24M | |
| Net Debt Issued | · | $-12M | · | |
| Stock Repurchased | $60M | $60M | · | |
| Net Stock Activity | · | $-60M | · | |
| Financing Cash Flow | $-354M | $-70M | $-86M | |
| Net Change in Cash | $-338M | $800M | $-9M | |
| Taxes Paid | $156M | $398.0K | $245.0K | |
| Free Cash Flow | · | $101M | · | |
| Levered FCF | · | $67M | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Gross Margin | 12.7% | 13.3% | · | |
| Operating Margin | 3.4% | 3.4% | · | |
| Net Margin | 2.2% | 4.1% | · | |
| Pretax Margin | 2.4% | 2.3% | · | |
| EBITDA Margin | 3.4% | 3.4% | · | |
| ROA | 1.4% | 2.5% | · | |
| ROE | 4.5% | 8.1% | · | |
| ROIC | 2.9% | 2.4% | · |
Liquidity & Solvency 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 1.6 | 1.7 | · | |
| Quick Ratio | 1.1 | 1.3 | · | |
| Debt / Equity | 1.1 | 1.3 | · | |
| LT Debt / Equity | 1.0 | 1.2 | · | |
| Interest Coverage | 3.5 | 3.1 | · |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | |
| Receivables Turnover | 3.7 | 3.5 | · |
Valuation (TTM) 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Revenue TTM | $13.97B | $12.97B | · | |
| Net Income TTM | $317M | $262M | · | |
| Market Cap | $45.22B | $27.44B | · | |
| Enterprise Value | $46.86B | $29.05B | · | |
| P/E | 159.0 | 118.4 | · | |
| P/S | 3.2 | 2.1 | · | |
| P/B | 22.1 | 13.9 | · | |
| P / Cash Flow | · | 223.2 | · | |
| P / FCF | · | 270.6 | · | |
| EV / EBITDA | 359.4 | 239.2 | · | |
| EV / FCF | · | 286.5 | · | |
| EV / Revenue | 3.4 | 2.2 | · | |
| Earnings Yield | 0.63% | 0.84% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 32 filers · $608.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 9 (+4 vs prior Q) | 5 (+3 vs prior Q) | 7 (-2 vs prior Q) | 12 (+3 vs prior Q) | -717K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VOYA INVESTMENT MANAGEMENT LLC | $270,102,618 | 1,179,745 | 44.42% | Shares |
| BlackRock, Inc. | $112,727,883 | 492,369 | 18.54% | Shares |
| Calamos Advisors LLC | $69,051,778 | 301,602 | 11.35% | Shares |
| VAN ECK ASSOCIATES CORP | $40,430,667 | 200,132 | 6.65% | Shares |
| INFRASTRUCTURE CAPITAL ADVISORS, LLC | $24,665,699 | 107,734 | 4.06% | Shares |
| FMR LLC | $20,993,500 | 90,800 | 3.45% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $12,497,187 | 54,193 | 2.06% | Shares |
| Point72 Asset Management, L.P. | $11,796,507 | 51,150 | 1.94% | Shares |
| GABELLI FUNDS LLC | $9,066,420 | 39,600 | 1.49% | Shares |
| BlueCrest Capital Management Ltd | $6,510,193 | 28,435 | 1.07% | Shares |
| ADVENT CAPITAL MANAGEMENT /DE/ | $6,116,688 | 26,427 | 1.01% | Shares |
| AMERIPRISE FINANCIAL INC | $5,287,331 | 23,000 | 0.87% | Shares |
| Invesco Ltd. | $4,121,100 | 18,000 | 0.68% | Shares |
| JANE STREET GROUP, LLC | $3,651,066 | 15,947 | 0.60% | Shares |
| Elequin Capital, LP | $3,228,951 | 14,046 | 0.53% | Shares |
| CSS LLC/IL | $1,386,889 | 6,014 | 0.23% | Shares |
| BARCLAYS PLC | $1,382,629 | 6,039 | 0.23% | Shares |
| SSI INVESTMENT MANAGEMENT LLC | $1,072,796 | 4,640 | 0.18% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,017,683 | 4,445 | 0.17% | Shares |
| Central Pacific Bank - Trust Division | $902,063 | 3,940 | 0.15% | Shares |
| GAMCO INVESTORS, INC. ET AL | $686,850 | 3,000 | 0.11% | Shares |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $286,188 | 1,250 | 0.05% | Shares |
| UBS Group AG | $233,529 | 1,020 | 0.04% | Shares |
| Warberg Asset Management LLC | $223,143 | 968 | 0.04% | Shares |
| Ares Systematic Credit Ltd | $211,321 | 923 | 0.03% | Shares |
| Virtus Fixed Income Advisers, LLC | $198,606 | 859 | 0.03% | Shares |
| MORGAN STANLEY | $175,147 | 765 | 0.03% | Shares |
| VIRTUS ADVISERS, LLC | $46,241 | 200 | 0.01% | Shares |
| ROYAL BANK OF CANADA | $34,000 | 147 | 0.01% | Shares |
| LORD, ABBETT & CO. LLC | $22,526 | 97,932 | 0.00% | Shares |
| HRT FINANCIAL LP | $1,087 | 4,751 | 0.00% | Shares |
| Virtu Financial LLC | $431 | 1,883 | 0.00% | Shares |
Company insiders 3 insiders · 2 officers · 2 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jon B Rousseau | Title: Chairman, President and Chief Executive Officer | July 25, 2026 F | 1,138,184 | 0 | 0 | $0 |
| Scott A. Greenwell | President, PharMerica | June 20, 2026 F | 34,372 | 0 | 0 | $0 |
| Nigam H. Shah | Director | June 11, 2026 A | 4,013 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| KKR Phoenix Aggregator L.P., KKR Phoenix Aggregator GP LLC, KKR Americas Fund XII L.P., KKR Associates Americas XII L.P., KKR Americas XII Limited., KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts | June 5, 2026 | 13.70% | Amendment | Capital structure | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.